Skip to content

Clinical trials

Completed Small Cell Lung Carcinoma trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Small Cell Lung Carcinoma Status: Completed Country / region: Belgium Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20022
20062
20071
20081
20091
20111
20131
20144
20152
20162
20172
20181
20192
20202
20213
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed31

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie3
Bristol-Myers Squibb3
Celgene2
Eli Lilly and Company2
European Lung Cancer Working Party2
Hoffmann-La Roche2
PharmaMar2
Amgen1
EMD Serono Research & Development Institute, Inc.1
ETOP IBCSG Partners Foundation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Small Cell Lung Carcinoma31
Carcinoma, Hepatocellular5
Carcinoma, Non-Small-Cell Lung5
Lung Neoplasms5
Carcinoma, Merkel Cell3
Carcinoma, Transitional Cell3
Mesothelioma3
Neoplasm Metastasis3
Ovarian Neoplasms3
Melanoma2

Trials

Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.